Found 190 matching trials
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor PHASE2 This is a Phase II, open-label, two strata, multicenter, prospective study ...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers PHASE1 Diabetic foot ulcers, a complication of diabetes leading to 80.000 lower li...
Show More Location
Helen L. & Martin S. Kimmel Wound Healing Center at the NYU Hospital for Joint Diseases
Learn More & Join Trial
AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia PHASE1 This study is a phase I/II study to determine the safety and efficacy of AM...
Show More Location
Washington University
Learn More & Join Trial
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas PHASE1 This phase I/II trial studies the side effects and best dose of temozolomid...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease PHASE1 This is an open-label, single-arm, multicenter, Phase 1/2 study evaluating ...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Reduced Intensity Transplantation for Severe Sickle Cell Disease PHASE2 This study is being done to test a transplant method that may have fewer si...
Show More Location
St. Jude Children's Research Hospital
Treatments Being Tested
hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus Learn More & Join Trial
Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation PHASE1 Generic plerixafor use at reduced-dose for mobilization on HSCT transplant...
Location
Universidad Autónoma de Nuevo León
Learn More & Join Trial
Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma PHASE2 This phase II trial studies how well whole brain radiation therapy works wi...
Show More Location
Stanford Cancer Institute Palo Alto
Learn More & Join Trial